UPDATE: Kymera Therapeutics (KYMR) PT Lowered to $70 at Stifel
Tweet Send to a Friend
(Updated - February 24, 2022 3:47 PM EST)
Stifel analyst Bradley Canino lowered the price target on Kymera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Bradley Canino lowered the price target on Kymera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
